The NanoMedicines Innovation Network (NMIN) is advancing “smart” medicines to cure disease by delivering small molecule drugs more specifically to disease sites and enabling the clinical use of gene therapies.
NMIN brings investigators from universities across Canada—a multidisciplinary collective of physicists, engineers, chemists, biochemists, cell biologists, disease specialists, and clinicians—together with companies and not-for-profit research and granting institutions to expand and improve Canada’s position as world leader in nanomedicines R&D.
NMIN invests in projects aimed at developing new therapeutics and diagnostics. Particular efforts are made to conduct projects partnered with industry to ensure market impact.
NMIN is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.
Company Details
- Employees
- 7
- Address
- 2350 Health Sciences Mall, Vancouver,british Columbia V6t 1z3,canada
- Industry
- Research
- Website
- https://nanomedicines.ca
- HQ
- Vancouver, British Columbia
Nanomedicines Innovation Network Questions
Nanomedicines Innovation Network's website is https://nanomedicines.ca
Nanomedicines Innovation Network's LinkedIn profile is https://ca.linkedin.com/company/nmin
Nanomedicines Innovation Network has
7 employees.
View email and phone details for 7
employees at Nanomedicines Innovation Network.
Nanomedicines Innovation Network's industry is
Research
Nanomedicines Innovation Network's top competitors are
Martket Health,
Acuitas Therapeutics,
Admare Bioinnovations,
Controlled Release Society,
Integrated Nanotherapeutics Inc.,
Cerecura Nanotherapeutics,
Northmirs,
Nanovation Therapeutics™,
Notch Therapeutics,
Polymorphic Bioscience Inc..
Nanomedicines Innovation Network's categories are Research
